High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation
AuthorsLiberante, Fabio G.
Boncheva, Viktoriya Bogdanova
Bowen, David T.
Mills, Ken I.
Preferentially expressed Antigen of the Melanoma Gene
MetadataShow full item record
CitationLiberante, F.G., Pellagatti, A., Boncheva, V., Bowen, D.T., Mills, K.I., Boultwood, J. & Guinn, B.A. (2013) 'High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation' British Journal of Haematology. 162 (2) pp 282-284.
JournalBritish Journal of Haematology
SponsorsThis work was supported in part by Wessex Medical Research and a Wellcome Value In People award (BG), Northern Ireland Leukaemia Research Fund (NILRF) and the NI Department of Education and Learning (FL) and Leukaemia and Lymphoma Research (AP and JB).